| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034416034 |
| P356 | DOI | 10.1038/NPP.2010.208 |
| P932 | PMC publication ID | 3055737 |
| P698 | PubMed publication ID | 21150907 |
| P5875 | ResearchGate publication ID | 49676684 |
| P50 | author | Deborah Mash | Q545893 |
| Wolfgang Sadee | Q57715733 | ||
| P2093 | author name string | Audrey C Papp | |
| Danxin Wang | |||
| Ryan M Smith | |||
| Robert A Moyer | |||
| Linda Duque | |||
| P2860 | cites work | Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution | Q46301222 |
| Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients | Q46422249 | ||
| Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations | Q46437618 | ||
| Catechol O-methyl transferase and dopamine D2 receptor gene polymorphisms: evidence of positive heterosis and gene-gene interaction on working memory functioning | Q46669352 | ||
| Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials | Q46670494 | ||
| Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment | Q46771444 | ||
| Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism | Q47861272 | ||
| Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers | Q48279855 | ||
| Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. | Q48402642 | ||
| Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors | Q48452772 | ||
| Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves | Q73433725 | ||
| Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patients | Q79464438 | ||
| D2 dopamine receptor gene haplotypes and their influence on alcohol and tobacco consumption magnitude in alcohol-dependent individuals | Q80384984 | ||
| Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias | Q95825809 | ||
| NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory | Q22241980 | ||
| A second generation human haplotype map of over 3.1 million SNPs | Q24651939 | ||
| Distinct functions of the two isoforms of dopamine D2 receptors | Q28138415 | ||
| Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor | Q28205599 | ||
| The evolutionary significance of cis-regulatory mutations | Q28288545 | ||
| A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia | Q28307335 | ||
| Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions | Q28509227 | ||
| Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice | Q28509965 | ||
| Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning | Q28590865 | ||
| SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap | Q29614907 | ||
| Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. | Q30445824 | ||
| Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance | Q33533750 | ||
| Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans | Q33711011 | ||
| Abundant raw material for cis-regulatory evolution in humans | Q34157325 | ||
| SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families | Q34309797 | ||
| The genetic basis for smoking behavior: a systematic review and meta-analysis | Q35888652 | ||
| The principal features and mechanisms of dopamine modulation in the prefrontal cortex | Q35894171 | ||
| Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics | Q36076320 | ||
| Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. | Q36300098 | ||
| Prominence of the dopamine D2 short isoform in dopaminergic pathways | Q36507451 | ||
| Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. | Q37092462 | ||
| Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. | Q37201805 | ||
| Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues | Q37208437 | ||
| Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics | Q37264543 | ||
| Correlating human and animal studies of cocaine abuse and gene expression. | Q37320712 | ||
| Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. | Q37371260 | ||
| Genetics of dopamine receptors and drug addiction: a comprehensive review | Q37380521 | ||
| Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms | Q37384257 | ||
| The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia | Q38333775 | ||
| Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. | Q40392922 | ||
| Modification of enzymatically amplified DNA for the detection of point mutations. | Q40449450 | ||
| Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers | Q40538213 | ||
| New insights into dopamine receptors in the central nervous system | Q40708481 | ||
| Molecular diversity of the dopamine receptors | Q40908177 | ||
| D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis | Q42056580 | ||
| Association of DRD2 variants and Gilles de la Tourette syndrome in a family-based sample from a South American population isolate | Q43079137 | ||
| Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients | Q43268539 | ||
| The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans | Q45331716 | ||
| Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution | Q46047802 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alternative mRNA splicing, via spliceosome | Q21114084 |
| dopamine | Q170304 | ||
| P304 | page(s) | 753-762 | |
| P577 | publication date | 2010-12-08 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse | |
| P478 | volume | 36 |
| Q64227287 | A Genetic Variant in GPR126 Causing a Decreased Inclusion of Exon 6 Is Associated with Cartilage Development in Adolescent Idiopathic Scoliosis Population |
| Q48291259 | A comparison of genetic variants between proficient low- and high-risk sport participants |
| Q27312296 | A review of pharmacogenetic studies of substance-related disorders |
| Q33838931 | A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study |
| Q33578546 | ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse |
| Q35995415 | Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system |
| Q93349189 | Alcohol Activates Scabrous-Notch to Influence Associated Memories |
| Q64875803 | Alpha-synuclein mRNA isoform formation and translation affected by polymorphism in the human SNCA 3'UTR. |
| Q35731672 | Analyzing allele specific RNA expression using mixture models |
| Q37910743 | Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain |
| Q39016970 | Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment |
| Q45826484 | Association between DRD2/DRD4 interaction and conduct disorder: a potential developmental pathway to alcohol dependence |
| Q33618811 | Association between secreted phosphoprotein-1 (SPP1) polymorphisms and low bone mineral density in women |
| Q86196878 | Association of GPR126 gene polymorphism with adolescent idiopathic scoliosis in Chinese populations |
| Q41728666 | Association of IRF8 gene polymorphisms with autoimmune thyroid disease |
| Q33854534 | Association of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder |
| Q37401604 | Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction |
| Q34515721 | Association of mitochondrial DNA polymerase γ gene POLG1 polymorphisms with parkinsonism in Chinese populations |
| Q88945720 | Association of ulcerative colitis with solute-linked carrier family 26 member A3 gene polymorphisms and its expression in colonic tissues in Chinese patients |
| Q36043366 | BDNF promoter methylation and genetic variation in late-life depression |
| Q21999524 | Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens. |
| Q46501122 | Cocaine-induced adaptation of dopamine D2S, but not D2L autoreceptors |
| Q36402504 | Common variants in DRD2 are associated with sleep duration: the CARe consortium |
| Q36337087 | Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression |
| Q64777182 | DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum |
| Q50270226 | DRD2 and ANKK1 genes associate with late-onset heroin dependence in men. |
| Q33599626 | DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory |
| Q46392449 | DRD2/DRD4 heteromerization may influence genetic susceptibility to alcohol dependence |
| Q36075672 | Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium. |
| Q38865983 | Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study |
| Q27021853 | Dopamine signaling in food addiction: role of dopamine D2 receptors |
| Q21129462 | Dopamine signaling in reward-related behaviors |
| Q36593856 | Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction |
| Q58115044 | Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction |
| Q38086129 | Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight |
| Q34042444 | Expression of mRNA transcripts encoding membrane transporters detected with whole transcriptome sequencing of human brain and liver |
| Q30663128 | Finding the lost treasures in exome sequencing data |
| Q28394896 | Gene-environment interactions in male reproductive health: special reference to the aryl hydrocarbon receptor signaling pathway |
| Q39115205 | Genetic factors associated with iron storage in Australian blood donors |
| Q37030993 | Genetic influences on nicotinic α5 receptor (CHRNA5) CpG methylation and mRNA expression in brain and adipose tissue |
| Q64988737 | Genetics of cocaine and methamphetamine consumption and preference in Drosophila melanogaster. |
| Q37986616 | Genetics of dopamine receptors and drug addiction |
| Q42543429 | Genome-wide DNA polymorphisms in low Phosphate tolerant and sensitive rice genotypes. |
| Q52884101 | Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients. |
| Q28536350 | Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety |
| Q37376944 | HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations |
| Q33745451 | Immune-mediated animal models of Tourette syndrome |
| Q92164026 | Impact of CHRNA5 polymorphisms on the risk of schizophrenia in the Chinese Han population |
| Q38709125 | KLF11 is an Epigenetic Mediator of DRD2/Dopaminergic Signaling in Endometriosis |
| Q33676705 | MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant |
| Q89326887 | Molecular windows into the human brain for psychiatric disorders |
| Q36353466 | Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults. |
| Q35439069 | Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans |
| Q92705761 | Personality Traits or Genetic Determinants-Which Strongly Influences E-Cigarette Users? |
| Q35120999 | Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect |
| Q35654120 | Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy |
| Q41477739 | RNAseq revealed the important gene pathways controlling adaptive mechanisms under waterlogged stress in maize. |
| Q37223916 | Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients |
| Q35844253 | Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability |
| Q92130946 | Sex-specific role of CYP24A1 rs2762939 in the risk of essential hypertension based on the serum vitamin D and total renin concentrations |
| Q35583316 | Specific knockdown of the D2 long dopamine receptor variant |
| Q28535422 | Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine |
| Q41684455 | Stress-Induced Reduction of Dorsal Striatal D2 Dopamine Receptors Prevents Retention of a Newly Acquired Adaptive Coping Strategy. |
| Q89185657 | Study of the association of forkhead box P3 (FOXP3) gene polymorphisms with unexplained recurrent spontaneous abortions in Indian population |
| Q33579769 | The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction |
| Q54947826 | The frequency of DRD2 rs1076560 and OPRM1 rs1799971 in substance use disorder patients from the United Arab Emirates. |
| Q46238415 | The role of introns in the conservation of the metabolic genes of Arabidopsis thaliana |
| Q30277983 | The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations |
| Q42201173 | Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions |
| Q42949475 | What is a functional genetic polymorphism? Defining classes of functionality |
| Q39006186 | Whole genome sequence study of cannabis dependence in two independent cohorts |
| Q42643812 | Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients |
| Q37424880 | mRNA changes in nucleus accumbens related to methamphetamine addiction in mice |
| Q35913120 | mRNA transcript diversity creates new opportunities for pharmacological intervention |
Search more.